Haupt Pharma AG
- Company typePrivate
- Founded2000
- HeadquartersBerlin, Germany
- Headcount101–250
- GTM typeB2B
- OfferingServices
Haupt Pharma AG firmographics
Firmographics- Name
- Haupt Pharma AG
- Legal name
- Aenova Group AG
- Website
- https://haupt-pharma.de
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Haupt Pharma AG industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)
- akta.pro secondary industry
- Manufacturing, Private Label & Co-Manufacturing for Animal Diets (HLAMAHAO)
Keywords
Where Haupt Pharma AG is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Markets served
Haupt Pharma AG business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D
Distribution channels1 record
Marketing channels6 records
Haupt Pharma AG product offering
Product offeringCore offering
The company operates as a contract manufacturer for the pharmaceutical and healthcare industry, manufacturing drug products in formats including hard capsules and sterile technologies, providing pharmaceutical development and technology services, and producing animal health products. It serves pharmaceutical and healthcare companies as a B2B outsourcing partner, allowing clients to access specialized manufacturing capacity and development capabilities without investing in proprietary production infrastructure.
Product overview
The source content describes Aenova Group, a worldwide leading contract manufacturer for the pharmaceutical and healthcare industry. No information about Haupt Pharma AG products or services is present in the provided source data.
Differentiator
Problem solved
Functional benefit
Products and services
- Hard Capsule Contract Manufacturing Contract manufacturing of hard capsule dosage forms for pharmaceutical companies; produces encapsulated drug products on behalf of clients, enabling them to outsource capsule production without operating dedicated facilities.
- Sterile Technologies Manufacturing Contract manufacturing of sterile pharmaceutical dosage forms (e.g., aseptic / sterile products) for pharmaceutical clients; relies on dedicated sterile manufacturing facilities such as the Latina, Italy competence center.
- Pharmaceutical Development & Technology Services Development and technology services for pharmaceutical formulation, process development, and manufacturing technology, helping clients bring drug products from development through manufacturing scale-up.
- Animal Health Product Manufacturing Contract manufacturing of animal health products, including veterinary pharmaceuticals and health-related products for the animal health market.
Companies that use Haupt Pharma AG
Customer profileSegments2 records
Ideal customer profiles2 records
Haupt Pharma AG technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Haupt Pharma AG partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
Haupt Pharma AG competitors and assessment
Company assessmentDirect peers
- Hovione: Private Portuguese CDMO specializing in APIs, particle engineering, and contract manufacturing. Comparable business model serving similar pharma customers with development and manufacturing services.
- Alcami Corporation: US CDMO offering sterile and oral solid dose manufacturing services. Directly comparable service mix to Aenova, particularly in sterile technologies, serving pharma clients.
- Recipharm: European-headquartered pharmaceutical CDMO offering solid dose, sterile, and biologics manufacturing services. Closest peer to Aenova given similar geography, customer base, and contract manufacturing scope.
- Cambrex: US-based CDMO providing API and finished dosage form development and manufacturing. Comparable to Aenova in its contract manufacturing focus on small molecules and pharma customers.
- Siegfried Holding: Swiss-listed CDMO providing API and finished drug manufacturing services, including sterile fill-finish. Comparable to Aenova as a European mid-to-large CMOs serving global pharma clients.
- NextPharma: European CDMO focused on pharmaceutical contract manufacturing across multiple dosage forms. Direct peer to Aenova in terms of geography, service offering, and customer base.
Broad incumbents
- Lonza Group: Global leading CDMO with strengths in biologics, APIs, and small molecules. Broader and larger than Aenova, but competes for the same pharma outsourcing wallet share.
- Catalent: Major US-headquartered CDMO with deep softgel, oral, and sterile capabilities; now under Novo Holdings. Comparable service portfolio and target pharma customer base, but at a meaningfully larger scale than Aenova.
- WuXi STA (WuXi AppTec): China-based large CDMO offering API and drug product manufacturing globally. Significant competitor in same CDMO market, with structural cost advantages putting pricing pressure on European peers like Aenova.
- Patheon (Thermo Fisher Scientific Pharma Services): Pharma services division of Thermo Fisher offering drug development and commercial manufacturing. Overlaps with Aenova's CDMO/CMO offering but as part of a much broader life sciences tools and services portfolio.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Haupt Pharma AG social profiles
Digital presenceHaupt Pharma AG financial estimates
Financial estimateRevenue estimate
Valuation estimate
Haupt Pharma AG leadership team
Management profileNumber of profiles
Haupt Pharma AG funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Haupt Pharma AG M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Haupt Pharma AG
What does Haupt Pharma AG do?
The company operates as a contract manufacturer for the pharmaceutical and healthcare industry, manufacturing drug products in formats including hard capsules and sterile technologies, providing pharmaceutical development and technology services, and producing animal health products. It serves pharmaceutical and healthcare companies as a B2B outsourcing partner, allowing clients to access specialized manufacturing capacity and development capabilities without investing in proprietary production infrastructure.
When was Haupt Pharma AG founded?
Haupt Pharma AG was founded in 2000. It employs 101 to 250 people.
Where is Haupt Pharma AG based?
Haupt Pharma AG is headquartered in Berlin, Germany, in the Europe region.
Who are Haupt Pharma AG's main competitors?
Direct peers on record are Hovione, Alcami Corporation, Recipharm, Cambrex, Siegfried Holding and NextPharma. Broad incumbents are Lonza Group, Catalent, WuXi STA (WuXi AppTec) and Patheon (Thermo Fisher Scientific Pharma Services).
Does Haupt Pharma AG have an API?
No public API is recorded for Haupt Pharma AG.
What industry is Haupt Pharma AG in?
Haupt Pharma AG's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO), with a secondary code of HLAMAHAO, Manufacturing, Private Label & Co-Manufacturing for Animal Diets. Its NAICS code is 325412 and its SIC code is 2834.